Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers-Reference-Cited by-同舟云学术

Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers

Published:2007-02 Issue:2 Volume:28 Page:289-298
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Dearth Lawrence R.,Qian Hua,Wang Ting,Baroni Timothy E.,Zeng Jue,Chen Stephanie W.,Yi Sun Young,Brachmann Rainer K.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/28/2/289/17285482/bgl132.pdf

Reference60 articles.

1. The p53 pathway;Prives;J. Pathol.,1999

2. Surfing the p53 network;Vogelstein;Nature,2000

3. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest;Corcoran;Cancer. Biol. Ther.,2004

4. A global map of p53 transcription-factor binding sites in the human genome;Wei;Cell,2006

5. Transcriptional repression mediated by the p53 tumour suppressor;Ho;Cell. Death Differ.,2003

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Agnostic Therapy—The Final Step Forward in the Cure for Human Neoplasms?;Cells;2024-06-20

2. Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators;Cell Death & Disease;2024-06-11

3. A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms;Current Oncology;2024-04-23

4. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer;Cancer Medicine;2024-02

5. Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma;World Journal of Clinical Oncology;2024-01-24